-
How to Drive Value in the Digital Transformation Era?
-
Application of Distributional Cost-Effectiveness Analysis to the US Setting
-
Innovative Uses of Technology to Advance Health Preference Research
-
The Use of Real-World Evidence in HTA in Central and Eastern Europe
-
Communicating High Value in Scientific Publications
-
September 6-7: Targeted Learning for Generating Real-World Evidence in Evolving Regulatory Landscape-Virtual
-
August 22-23: Selecting Rapid Review Methods for Health Technology Assessment- Virtual
-
Driving Health Outcomes: Exploring Value-Based Procurement
-
August 7-8: Economic Model Review: Quality Control, Strategic Assessment and Reporting Standards- Virtual
-
Health is Wealth
-
July 25-26: Model Calibration in R- Virtual
-
Economic Evaluation of Digital Health Technologies
-
July 19: Learning and Applying Discrete Event Simulation- Virtual
-
Assessing Causal Treatment Effect for Sequenced Oncology Regimens
-
June 28-29: Valuing Health: The Generalized Risk Adjusted Cost Effectiveness (GRACE) Model- Virtual
-
FDA Patient-Focused Drug Development (PFDD) Guidance - Part 3
-
Assessment of Digital Health Technologies in the Asia Pacific Region
-
June 6-7: Pharmacoeconomic Modeling-Applications- Virtual
-
Challenges in Rare Disease Diagnostics: An Overview
-
Clinical Trial Innovation: How Healthcare Technology is Evolving